๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Predictors of fluoxetine remission for hospitalized patients with major depressive disorder

โœ Scribed by Ching-Hua Lin; Hsien-Yuan Lane; Cheng-Chung Chen; Suh-Hang Hank Juo; Cheng-Fang Yen


Book ID
108962699
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
81 KB
Volume
65
Category
Article
ISSN
1323-1316

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparison of pramipexole, fluoxetine, a
โœ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 195 KB ๐Ÿ‘ 2 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Predictors of response to sertraline in
โœ Shigeru Morishita; Toshihiko Kinoshita ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 1 views

## Abstract ## Objective Investigation of the characteristics of patients being treated with antidepressants would be useful in determining which patients would most likely benefit from antidepressant. The purpose of this study was to examine the possible predictors of response to sertraline in ma